RESPONSE BIOMEDICAL CORP Net Cash Provided by (Used in) Operating Activities, Continuing Operations
RESPONSE BIOMEDICAL CORP reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -CAD 1.29 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2016-11-14
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was 147.00K CAD, a 91.14% decline year-over-year.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was 270.00K CAD, a 33.82% decline year-over-year.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-03-31 was -1.71M CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for the quarter ending 2015-12-31 was 31.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was 813.00K CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -2.29M CAD.
- RESPONSE BIOMEDICAL CORP net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -1.27M CAD.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2016-09-30 | 147.00K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 417.00K CAD derived: sum of 2 quarters · filed 2016-11-14 | -1.29M CAD 10-Q · filed 2016-11-14 | -1.26M CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | 270.00K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -1.44M CAD 10-Q · filed 2016-08-15 | -1.41M CAD derived: sum of 3 quarters · filed 2016-08-15 | 249.00K CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-03-31 | -1.71M CAD 10-Q · filed 2016-05-16 | -1.68M CAD derived: sum of 2 quarters · filed 2016-05-16 | -21.00K CAD derived: sum of 3 quarters · filed 2016-11-14 | 387.00K CAD derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | 31.00K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | 1.69M CAD derived: sum of 2 quarters · filed 2016-11-14 | 2.10M CAD derived: sum of 3 quarters · filed 2016-11-14 | 813.00K CAD 10-K · filed 2016-03-24 |
| 2015-09-30 | 1.66M CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 2.07M CAD derived: sum of 2 quarters · filed 2016-11-14 | 782.00K CAD 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 408.00K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -878.00K CAD 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | -1.29M CAD 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | -2.29M CAD 10-K · filed 2016-03-24 | |||
| 2013-12-31 | -1.27M CAD 10-K · filed 2016-03-24 |